A comprehensive review of immune checkpoint inhibitors for cancer treatment

Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment

Treatment-related adverse events of PD-1 and PD-L1 inhibitor-based combination therapies in clinical trials: a systematic review and meta-analysis

Are immune-related adverse events associated with the efficacy of immune checkpoint inhibitors in patients with cancer? A systematic review and meta-analysis